Institutional investors purchased a net $5.9 thousand shares of MNOV during the quarter ended June 2015. This may signal that the smart money is gaining interest in this company as the 4.21% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
GEODE CAPITAL MANAGEMENT LLC Bought 31.4 Thousand shares of MediciNova Inc
THE VANGUARD GROUP, INC. Bought 23.7 Thousand shares of MediciNova Inc
BRIDGEWAY CAPITAL MANAGEMENT, IN... Bought 22.9 Thousand shares of MediciNova Inc